APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. - Wikidata - wikimedia - TriplyDB

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

http://www.wikidata.org/entity/Q33826968

about

APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all HIV-1 reverse transcription Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F Interaction of APOBEC3A with DNA assessed by atomic force microscopy Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Functional comparison of innate immune signaling pathways in primates Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.Interferon-inducible effector mechanisms in cell-autonomous immunity.Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function Alcohol enhances HIV infection of cord blood monocyte-derived macrophages N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.Morphine suppresses IFN signaling pathway and enhances AIDS virus infection.Stably expressed APOBEC3F has negligible antiviral activity.APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.Ex vivo gene therapy for HIV-1 treatment.Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells.The role of unintegrated DNA in HIV infection The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia.APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.DNA Editing of LTR Retrotransposons Reveals the Impact of APOBECs on Vertebrate Genomes.

P2860

Q24310242-90EB134E-15F6-4D8E-92A8-CC2EB7F1A4AF Q24611223-237C6791-FC10-4767-A189-97304635F12A Q26823568-F3EA8E4C-9E78-4537-B0B4-D114AB6136AE Q27023387-D74BFF9A-DB52-45B4-B52B-B5A5267A5ED7 Q27025150-AF478EAD-6009-49E6-95A0-125BF3A5ADEB Q27680506-BF3C6883-485B-433D-8DD3-7104C5D3B8E9 Q28539478-5BA73E77-6DE3-4A6D-AFC0-10D23A7DEE85 Q28541264-DB4F25F8-B083-4237-9DEE-9A19E9102B39 Q33589167-09AB9829-50EC-467A-A019-0B9D17EEB501 Q33780976-EA3700D8-7BF6-41FD-AA1D-E5A93540011E Q33877299-AF38A4F7-CE0A-430B-96C2-3CD6A9050FAC Q33982561-FB7A836A-53B9-4094-80BC-0776B6AA52B6 Q34114819-ADFCABD8-E1F8-4D51-8909-57F4E5FA63D8 Q34120768-7F2CA704-433D-43A8-9C59-5FAA55A47C86 Q34129449-D794DF1F-18E0-4CAF-890B-064E81018627 Q34166447-41519C46-6921-4025-8299-13D7808FB7E7 Q34168153-2680E748-C588-4A39-B941-FC3F956F6D36 Q34190587-3ADF797A-108A-4ED8-A581-41EFA68CDA3B Q34352429-08F7650A-E984-4B62-B618-74F19707461F Q34412763-E0889F11-7819-4AA5-AC85-35C04A6EFA52 Q34416665-5E3F567E-DF39-4A92-BA3A-EC14FD2BBAA7 Q34539110-8ED6A368-3AAF-4788-B6E2-CEC909D0CC3D Q34742607-D4E6830D-4428-4E45-A0B9-077E8A640B87 Q34761552-32C434EA-EBBB-4B90-B5B0-7261A6A4D3A5 Q34982851-6C460099-74F4-48E2-A086-7463064D06C0 Q35076674-B2E00A21-635B-4BA1-B569-C04745D31218 Q35143730-865FD9BA-8079-4056-9634-5FA7E38D1A7B Q35192821-952ED578-F70B-4413-9C6A-7DD4B0097439 Q35668959-8533E0D4-685A-4C65-8104-F12E9ACF4E31 Q35776289-AEA492A4-5B28-4D74-AAF9-9AC4AC277A91 Q35945852-B68854F3-33D8-47B8-A28C-0CF1D0C7DD30 Q36019696-4A219535-90CB-44EB-9BC1-808E0B01A392 Q36019742-0FEEC43C-5CE1-4E29-99BF-B7F391EB9BFC Q36156679-80F43671-B98C-41D7-A993-F4D6A3DDBD96 Q36432758-D35EA471-C428-4BDB-9E64-9C5C4E5D9D61 Q36506765-7EB676CF-D9EF-44D4-AD1B-D242121BA25D Q36811931-D56E6FD1-4F60-4F38-84F5-B733455711EF Q36827159-8F09298C-E97F-451B-BDF9-EA829B88A7EB Q36827236-8AAEB1AB-DBD6-437F-8D3F-726A566490F7 Q36899956-BA5A22F2-B153-47DA-842F-BCB40A794A36

P2860

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

http://www.wikidata.org/entity/Q33826968

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@ast

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@en

type

label

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@ast

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@en

prefLabel

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@ast

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

@en

P1433

Q33826968-78D3EC68-00F0-475F-8759-83695DA87EC6

P1476

Q33826968-F56E3FA8-96B8-4EDC-8870-D2C0E2E3D10E

P2093

Q33826968-4EF235CC-599C-42B3-8803-D6C3F6A9FF6D

Q33826968-58CE6FB7-72EE-440D-887E-00010009B5FA

P2860

Q33826968-03FEB930-31E7-48B1-ABC5-6A3CAE450FDA

Q33826968-08A6D566-7C09-45C1-9568-436F9FD807F5

Q33826968-0A4F6423-FCF3-466E-8BC0-2D6FF1978310

Q33826968-0B4C8BFC-4E3D-43FC-98DC-5D75E6AE3B1A

Q33826968-12DD8315-741D-4CE9-9080-E74A3B50B23A

Q33826968-164C0AEF-0CD5-4A4A-8B79-72435B55ECC2

Q33826968-1ED75D50-529C-403C-BAE0-5683D321E54E

Q33826968-26CB67FF-685A-45E9-82DB-AAE792E6CEB3

Q33826968-2B34E27C-DF19-4426-9F72-F9AE1EB9732B

Q33826968-2EC52CAC-9025-4880-A1DF-7734B5D32686

P304

Q33826968-9A61E79F-DA81-4FDF-93E1-524C0BBCE006

P31

Q33826968-62D62BDD-3C9B-41D8-8F83-8EF5B89B53DC

P356

Q33826968-F757A676-F06F-4E9E-8ED2-E4F31110F283

P433

Q33826968-9F544A71-E3C2-474E-BC84-8BE790776A5F

P478

Q33826968-40598BAC-7331-4DE9-8C47-E12FDD499769

P50

Q33826968-D1278003-8CA2-4692-A6D7-7547074F1E5A

P577

Q33826968-9EF7AADC-584D-430C-B311-F7FD4BCC4167

P698

Q33826968-615ED26A-D529-401D-A136-7B3996E4AA17

P932

Q33826968-6AFC484C-8C1D-4811-A7E0-AB01070C4F55

P356

P1433

Journal of Virology

P1476

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms

@en

P2093

Jean L Mbisa

http://www.w3.org/2001/XMLSchema#string

Wei Bu

http://www.w3.org/2001/XMLSchema#string

P2860

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

APOBEC3G targets human T-cell leukemia virus type 1.

Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

P304

5250-5259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02358-09

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Vinay K. Pathak

P577

2010-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20219927

http://www.w3.org/2001/XMLSchema#string

P932

2863843

http://www.w3.org/2001/XMLSchema#string